KeChow Pharma
A Shanghai-based innovative drug R&D company focused on oncology, founded in 2014.
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Shanghai KeChow Pharmaceutical Co., Ltd. was established in 2014. It is a high-tech pharmaceutical enterprise that integrates R&D, production, and marketing, focusing on innovative drug development with independent intellectual property. The company is dedicated to developing best-in-class small molecule drugs for oncology and other therapeutic areas, aiming to address unmet clinical needs in China and globally.
History
Shanghai KeChow Pharmaceutical Co., Ltd. was established in 2014. The company was founded by a team of high-level returned talents. In 2009, the company was established in Tianjin, focusing on small molecule anti-tumor drug R&D. In 2024, its self-developed MEK inhibitor, Keluping (trametinib), was approved by NMPA for NRAS-mutant advanced melanoma patients who failed PD-1/PD-L1 treatment. The company also entered into collaborations with Roche in 2021 and Sinopharm in 2024.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/kechow-pharma-china · Editorial policy · How profiles are compiled